Alloimmunization following antigen-negative red blood cell transfusion

Transfusion. 2023 Feb;63(2):430-434. doi: 10.1111/trf.17208. Epub 2022 Dec 1.

Abstract

Background: Red blood cell (RBC) alloimmunization can occur secondary to transfusion or pregnancy. It is observed most frequently among patients with hemoglobinopathies and myeloid neoplasms. Although previous antigen exposure is generally required for alloimmunization, some alloantibodies may develop naturally without prior exposure. Other alloantibodies may become evanescent, only to reemerge at a detectable titer following a stimulatory event. In a minute fraction of cases, 'non-naturally occurring' alloantibodies may appear without a known antigenic stimulus.

Methods and materials: All testing (antibody detection tests and identification, antigen phenotyping, and crossmatching) was performed using the same method and reagents, but occurred at two hospitals within the Yale New Haven Hospital delivery network, and was performed by technologists utilizing different instruments and reagent lots.

Results: We present two cases of seemingly de novo alloimmunization (anti-E and anti-K), and one case of re-emergence of a known, previously evanescent alloantibody (anti-K) following transfusion of RBCs that were antigen-negative for the corresponding antibodies.

Conclusion: While the exact mechanism underlying the development and/or re-emergence of RBC alloantibodies in the absence of antigenic stimulation remains unclear, these cases highlight this unusual phenomenon, underscoring the general immunogenicity, as well as the potential consequences, of RBC transfusion and reiterates the importance of concluding an alloantibody specificity, even in the absence of known transfusion of RBCs with a particular antigen.

Keywords: alloantibodies; alloimmunization; antigen-negative blood; blood transfusion; immunohematology; immunology; red blood cell antigen; red blood cells.

Publication types

  • Case Reports

MeSH terms

  • Blood Group Antigens*
  • Blood Transfusion
  • Erythrocyte Transfusion* / adverse effects
  • Erythrocyte Transfusion* / methods
  • Erythrocytes
  • Female
  • Humans
  • Isoantibodies
  • Pregnancy

Substances

  • Isoantibodies
  • Blood Group Antigens